The return of the long-extinct wooly mammoth or dodo bird may sound like a storyline straight out of science fiction. It’s not. Several de-extinction projects all share an ambitious aim to resurrect ...
IEEE Spectrum on MSN
Can biologists rewrite the genome’s spaghetti code?
New tools aim to turn DNA into something engineers can design ...
Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change how we prevent disease, age, and define human potential. The same tools ...
Changing an organism’s genome is a profound act, and the tools you use to make the changes don’t alleviate the need for responsible regulation. Unlike “traditional” genetically modified organisms (GMO ...
The UK is driving pioneering malaria research in areas including genetic engineering, vaccines, and medicines. In Tanzania, the scientists involved tell Nick Ferris why research to tackle the disease ...
(Reuters) - Scientists in China have manipulated embryonic stem cells to create laboratory mice with two male parents that managed to live to adulthood - though with significant developmental ...
Gene editing is now reaching the mainstream, ushering in a new era of genetic manipulation. Traditionally, inserting or deleting entire genes, regulating their expression, and altering specific ...
When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully synthetic genome, it marked a turning point in how scientists think about life.
'Return' of the dire wolf is an impressive feat of genetic engineering, not a reversal of extinction
Dallas-based biotech company Colossal has announced the birth of three pups bearing the DNA signatures of dire wolves, an iconic predator last seen roaming North America over 10,000 years ago. With ...
Colossal Secures $60M Series A Funding To Advance Genetic Engineering and De-extinction Technologies
DALLAS--(BUSINESS WIRE)--Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures ...
What if you could screen embryos for diseases before they became babies? What if you had the power to choose the traits your baby would have? Would you use it? These practically polar opposite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results